drug interaction
52 interactions related to drug interaction
smoking + theophylline
Smoke speeds up the liver's clearance of theophylline. The theophylline label says clearance is about 50% higher in young adult tobacco smokers and about 80% higher in elderly smokers, that marijuana smoking appears to increase it too, and that one week without tobacco cuts clearance by about 40%. Stopping smoking can therefore push levels toward a toxic range unless the dose is reviewed; nicotine gum had no effect on clearance.
smoking + propranolol
Cigarette smoking induces hepatic metabolism of propranolol (mainly via CYP1A2 and glucuronidation), increasing its clearance and lowering propranolol blood levels in smokers compared with non-smokers. Nicotine also independently raises heart rate, blood pressure, and circulating catecholamines, partly counteracting propranolol's beta-blocking effect. Both effects reverse when a person quits smoking.
methotrexate + nsaids
Methotrexate is cleared almost entirely by the kidneys. The methotrexate label lists aspirin and other NSAIDs among products that may raise methotrexate blood levels, and NSAIDs can reduce kidney blood flow and compete with methotrexate for elimination. Not every NSAID has been shown to raise levels: in the Celebrex label, celecoxib had no effect on methotrexate pharmacokinetics, but that label still warns that NSAIDs with methotrexate may increase the risk of methotrexate toxicity and asks for monitoring. The danger is greatest with high-dose methotrexate (cancer chemotherapy) or pre-existing kidney impairment, where buildup can cause bone marrow suppression, mouth and gut ulceration, liver injury, and acute kidney injury. In low-dose weekly methotrexate for autoimmune disease with healthy kidneys, the interaction is usually more modest and often manageable under prescriber supervision.
St. John's Wort + SSRI
St. John's Wort raises serotonin activity, and SSRI labels (including Zoloft, Prozac, Paxil, Celexa and Lexapro) list it among the products that increase the risk of serotonin syndrome, a potentially life-threatening reaction. It also speeds up CYP3A4 and the transporter P-glycoprotein, which may lower the levels of some antidepressants. Serotonin syndrome has been reported in older adults who combined antidepressants with the herb, so the advice is to avoid the combination.
alcohol + amitriptyline
Amitriptyline is a sedating tricyclic antidepressant with strong antihistaminic and anticholinergic effects. Combining it with alcohol, also a central nervous system depressant, produces additive drowsiness, impaired coordination and reaction time, and a greater risk of falls and accidents. The FDA label warns explicitly that amitriptyline may enhance the response to alcohol.
alcohol + bupropion
Bupropion can cause seizures, and its label lists excessive alcohol use as a factor that raises seizure risk. The label contraindicates bupropion in people who are abruptly stopping alcohol, because sudden alcohol withdrawal also raises the chance of a seizure. It also reports rare postmarketing cases of neuropsychiatric events or reduced alcohol tolerance in people who drank during treatment, and says alcohol should be minimized or avoided. The evidence is FDA label warnings and postmarketing reports, not a controlled study of the pair.
alcohol + theophylline
The theophylline labels list alcohol among clinically significant interactions: a single large dose of alcohol (3 mL of whiskey per kg of body weight) slows theophylline clearance for up to 24 hours, raising theophylline levels by about 30%. Theophylline has a narrow safe range, so a rise of that size can push some people toward side effects. The labels' example is a large amount of alcohol, and they do not give figures for lighter drinking.
nicotine + bupropion
Bupropion and nicotine replacement are often used together on purpose to help people quit smoking, and the combination worked well in a large trial. In that trial, high blood pressure that appeared during treatment was more common with bupropion plus a nicotine patch (6.1%) than with bupropion alone (2.5%), the patch alone (1.6%) or placebo (3.1%), and most affected people already had high blood pressure. The bupropion label therefore recommends blood pressure monitoring for people who use the two together.
alcohol + lithium
Lithium has a narrow therapeutic window and is cleared almost entirely by the kidneys. Alcohol promotes urination and dehydration, which can reduce renal lithium clearance and push serum lithium levels higher, toward the toxic range (tremor, confusion, unsteadiness, vomiting). Alcohol also independently destabilizes mood in bipolar disorder, and its early intoxication signs can mask the early warning signs of lithium toxicity.
cbd + simvastatin
Simvastatin is cleared mainly by the liver enzyme CYP3A4, and CBD inhibits that same enzyme in laboratory studies. Combining them could raise simvastatin exposure, which could increase the risk of muscle pain and, rarely, more serious muscle injury. This is a predicted interaction, not a confirmed one: the Epidiolex label reports that CBD did not change levels of midazolam, a sensitive CYP3A4 drug, and we found no human study of CBD with simvastatin.
alcohol + fluoxetine
Fluoxetine (Prozac) is an SSRI antidepressant, and alcohol is a central nervous system depressant. The Prozac Medication Guide, part of the FDA-approved label, says not to drink alcohol while using Prozac. Fluoxetine and its active metabolite norfluoxetine also have unusually long half-lives, so the drug stays in your system for weeks once you reach steady state: there is no simple "timing window" that avoids the interaction. In a small 1988 study of 12 healthy volunteers who took fluoxetine for 7 days, a measured dose of alcohol affected thinking and coordination tests about the same as with placebo. The current label does not report this finding, and the precaution remains sensible but is not an emergency.
alcohol + methylphenidate
Several long-acting methylphenidate labels, including Metadate CD, Jornay PM and Quillivant XR, say to avoid alcohol because it can speed up release of the dose; at 40% alcohol, Metadate CD released 84% of its methylphenidate in the first hour in lab testing. In small studies of healthy adults, alcohol also raised blood levels of active d-methylphenidate (AUC up 21% with short-acting methylphenidate; second-pulse peak up 35% with a long-acting form) and significantly strengthened stimulant effects. The studies did not measure harm.
caffeine + oral contraceptives
Ethinyl estradiol in combined oral contraceptives inhibits CYP1A2, the liver enzyme that clears caffeine. This slows caffeine's breakdown and prolongs its half-life, so the same cup of coffee can leave more caffeine circulating for longer and intensify jitteriness, insomnia and palpitations.
cbd + sirolimus
The sirolimus label says cannabidiol (CBD) may raise sirolimus blood levels and asks prescribers to monitor closely for toxicity. In a records review of 25 patients with tuberous sclerosis complex taking cannabidiol as a seizure medicine, trough levels of sirolimus or everolimus were higher in 76% after cannabidiol was added, with a median rise of 5.1 ng/mL for sirolimus. Over-the-counter CBD amounts have not been studied.
alcohol + warfarin
Heavy drinking is linked to more major bleeding on warfarin. In a US case-control study of 570 warfarin users (mean age 70), screening positive for moderate or severe alcohol misuse was linked to about twice the odds of major bleeding (OR 2.10), and heavy episodic drinking (5 or more drinks at once) to OR 2.36. This is an association, not proof of cause, and light, steady drinking was not what was studied.
alcohol + citalopram
Current citalopram oral solution labels say citalopram did not increase alcohol's effects on thinking and coordination in a clinical trial, but they still recommend against alcohol in people with depression, and their Medication Guide says not to drink while using citalopram. The current Celexa tablet label no longer carries this advice, so the label basis is weaker than for escitalopram. Citalopram can itself cause sleepiness, and alcohol adds its own impairment; no controlled study has shown that the combination is more harmful.
sertraline + st. john's wort
Sertraline is an SSRI that blocks serotonin reuptake, and St. John's wort independently raises central serotonin through constituents such as hyperforin and hypericin. Combining them can trigger serotonin syndrome, a potentially life-threatening reaction marked by altered mental status, autonomic instability, and neuromuscular hyperactivity. St. John's wort also speeds up CYP3A4 and CYP2C19, two of several liver enzymes that break down sertraline, so it could lower sertraline levels, but no study has measured this.
alcohol + fluvoxamine
The fluvoxamine label says studies of alcohol given with fluvoxamine found no effect of either drug on how the body handles the other or on their effects, but it still advises avoiding alcohol, as with other psychotropic medicines, and the Medication Guide says not to drink while using fluvoxamine. Two research groups found, in controlled studies of healthy men, that fluvoxamine did not make alcohol's impairment of thinking, memory or reaction time worse. Fluvoxamine can itself cause sleepiness or slow thinking and reactions, and alcohol adds its own impairment, so the advice rests on general caution rather than a measured clash.
metronidazole + alcohol
Oral metronidazole is linked to a disulfiram-like reaction with alcohol: abdominal cramps, nausea, vomiting, headaches and flushing. The current FDA label lists drinking alcohol, or using products that contain propylene glycol, during treatment and for at least three days after as a contraindication. Small controlled studies did not reproduce the reaction, so it may be uncommon, but the label's warning stands.
fluvoxamine + melatonin
Fluvoxamine strongly blocks CYP1A2, the liver enzyme that breaks down almost all of the melatonin you swallow. In a small study of 5 healthy men, taking melatonin with fluvoxamine left about 17 times more melatonin in the blood than melatonin alone, and fluvoxamine also raised the body's own nighttime melatonin in other volunteer studies. No study has measured whether this causes harm such as next-day sleepiness, and the fluvoxamine label does not mention melatonin, although it warns against ramelteon, a sleep medicine cleared the same way.
oral contraceptives + melatonin
Birth control pills appear to slow the body's breakdown of melatonin taken by mouth. In a study of 29 healthy volunteers given the same amount of melatonin, blood levels were 4 to 5 times higher in people using oral contraceptives than in those who were not, although the higher levels did not change how alert they were. The study compared users with non-users rather than the same people on and off the pill, and the exact mechanism is not settled.
pomegranate + statins (simvastatin, atorvastatin, lovastatin, rosuvastatin)
Pomegranate inhibits the drug-metabolizing enzyme CYP3A4 in laboratory and animal studies, raising a theoretical concern that it could increase blood levels of CYP3A4-dependent statins such as simvastatin, atorvastatin and lovastatin. However, controlled human studies, including one with simvastatin and one with midazolam, a sensitive CYP3A4 probe drug, did not find a meaningful effect, so pomegranate should not be treated like grapefruit. Rosuvastatin is included because of one case report of rhabdomyolysis (severe muscle breakdown) in a man taking rosuvastatin and ezetimibe after he started drinking pomegranate juice. Pravastatin, fluvastatin and pitavastatin do not rely on CYP3A4 and have no reports with pomegranate, so they are not covered. Concentrated pomegranate extract supplements warrant more caution than the whole fruit.
cbd + beta-blockers
CBD lowered blood pressure in a small human study: a single 600 mg dose cut resting systolic pressure by about 6 mmHg in 9 healthy men, though it raised their heart rate. That adds to the blood-pressure-lowering effect of every beta-blocker. In lab studies with human liver enzymes, CBD was also a potent blocker of CYP2D6, the enzyme that clears metoprolol, propranolol, carvedilol and nebivolol, so it could in theory raise their levels; this has not been measured in people. Atenolol, nadolol and bisoprolol rely little or not at all on CYP2D6.
fluconazole + grapefruit
Fluconazole is a moderate inhibitor of CYP3A4, and grapefruit blocks CYP3A4 in the gut wall. Grapefruit is unlikely to change fluconazole itself: the Diflucan label says over 90 percent of an oral dose is absorbed, food does not affect exposure, and about 80 percent leaves the body unchanged in the urine. No study has tested the pair. The theoretical concern is a third medicine with its own grapefruit warning, whose levels both could raise.
grapefruit + carbamazepine
Grapefruit juice inhibits the intestinal CYP3A4 enzyme that performs first-pass metabolism of carbamazepine, allowing more of each oral dose to reach the bloodstream. A human study in epilepsy patients found grapefruit juice raised carbamazepine blood levels, which matters because carbamazepine has a narrow safety margin.
cranberry + warfarin
Cranberry contains flavonoids and polyphenols that may slow CYP2C9, the liver enzyme that clears the more potent S-enantiomer of warfarin. Multiple human case reports describe a rising INR and serious bleeding in patients who took up cranberry juice or supplements while stably anticoagulated, and the effect appears to depend on how much cranberry is consumed: randomized trials using a modest daily amount have not consistently reproduced it.
noni juice + warfarin
Noni juice (Morinda citrifolia) products vary widely in vitamin K content, and one published case of warfarin resistance was attributed to a high-vitamin K noni preparation. Noni has also been linked to drug-induced liver injury, which can secondarily destabilize warfarin. The interaction is real but rests on case reports rather than large studies.
cranberry + tacrolimus
Cranberry has been shown to inhibit the gut CYP3A enzyme that breaks down tacrolimus, which would be expected to raise tacrolimus levels. But a 2016 case report, which its authors described as the first report of this pair, went the other way: a kidney transplant patient taking cranberry extract capsules had low tacrolimus levels that barely rose on a higher dose and came back up after she stopped the cranberry. The authors rated the link as possible, so the direction and size of any effect are uncertain. Because tacrolimus has a very narrow therapeutic window, any change in cranberry intake deserves a trough check.
alcohol + duloxetine
Duloxetine (Cymbalta) can occasionally cause liver injury, and liver failure, sometimes fatal, has been reported. Its FDA label says that because duloxetine and alcohol may interact to cause liver injury, it should not be prescribed to people with substantial alcohol use or evidence of chronic liver disease, and that heavy alcohol intake with duloxetine may be associated with severe liver injury. In a study described on the label, duloxetine did not add to alcohol's impairment of thinking and coordination; the concern is the liver.
alcohol + pregabalin
Pregabalin and alcohol are both central nervous system depressants. Taken together their sedative effects add up, increasing drowsiness, dizziness, and impaired coordination, and at the serious end can cause life-threatening respiratory depression: a risk highlighted by FDA and MHRA safety warnings.
caffeine + ciprofloxacin
Ciprofloxacin inhibits CYP1A2, the liver enzyme that clears caffeine from coffee, tea, cola, energy drinks and caffeine pills. In 10 healthy men, ciprofloxacin raised caffeine's half-life from 5.2 to 8.2 hours and its exposure (AUC) by about 60 percent, and cut its clearance by almost half. The Cipro label says ciprofloxacin may increase the effects of caffeine and that caffeine can build up; the study authors said the clinical significance was not yet known.
smoking + clozapine
Polycyclic aromatic hydrocarbons in tobacco smoke (not nicotine) induce CYP1A2, the liver enzyme that handles most clozapine metabolism; the Clozaril label calls tobacco smoke a moderate CYP1A2 inducer. Smokers tend to have lower clozapine levels: a meta-analysis of 4 studies (196 patients) estimated that non-smokers need about half the dose of smokers for the same level. The greater danger is stopping smoking: in 12 heavy smokers who quit, enzyme activity fell with a half-life of about 39 hours, so clozapine levels can climb within days, risking sedation, seizures and toxicity unless the dose is reviewed.
smoking + olanzapine
Polycyclic aromatic hydrocarbons in cigarette smoke induce CYP1A2, the main enzyme that breaks down olanzapine, so smokers clear the drug faster and run lower blood levels. When someone quits, levels rise over the following days to weeks and side effects can emerge on a previously stable dose. The effect is driven by combustion products, not nicotine.
smoking + caffeine
Polycyclic aromatic hydrocarbons in tobacco smoke induce CYP1A2, the main liver enzyme that breaks down caffeine, so smokers clear caffeine faster and feel it less. When you quit smoking, that fast clearance fades within a few days and your usual caffeine can build up, contributing to jitters, anxiety, palpitations, and poor sleep that can be mistaken for nicotine withdrawal.
smoking + insulin
Smoking worsens insulin resistance through nicotine-driven catecholamine release, oxidative stress, and inflammation, and slows subcutaneous insulin absorption through vasoconstriction, so people with diabetes who smoke typically need more insulin to reach the same glucose control. Quitting improves insulin sensitivity within days to weeks, so insulin doses often need to come down to avoid hypoglycemia.
cbd + tacrolimus
CBD inhibits CYP3A4, CYP3A5, and P-glycoprotein, the main pathways that clear tacrolimus. Case reports and a controlled pharmacokinetic trial show that adding CBD raises tacrolimus blood levels substantially, risking nephrotoxicity, neurotoxicity, and over-immunosuppression in transplant recipients, while stopping CBD abruptly can let levels crash and risk rejection.
cbd + sertraline
CBD inhibits CYP2C19, one of several enzymes that help break down sertraline, so adding CBD can raise sertraline exposure. A single published case report describes low sodium (hyponatremia) and cognitive decline in an older intermediate-metabolizer patient who added over-the-counter CBD to long-standing sertraline. The evidence is limited to this one report, so treat it as a reason for caution and prescriber discussion rather than a strong contraindication.
chamomile tea + warfarin
Chamomile contains naturally occurring coumarin-type compounds and may slow the liver enzymes that clear warfarin, so heavy or sudden chamomile use could add to warfarin's blood-thinning effect. A published case report linked frequent chamomile tea and lotion use to a dangerously high INR and severe internal bleeding in an older woman whose warfarin had previously been stable.
salt substitute + spironolactone
Most salt substitutes replace ordinary table salt with potassium chloride, so they act as concentrated potassium supplements. Spironolactone is a potassium-sparing diuretic that reduces how much potassium the kidneys excrete. Using the two together can drive potassium high enough to cause dangerous, sometimes life-threatening heart rhythm problems (hyperkalemia).
cocoa + warfarin
Cocoa flavanols can modestly reduce platelet activity in people, which in theory could add to warfarin's anticoagulant effect. In practice the evidence is mechanistic only: no case reports or clinical studies show actual bleeding or a change in INR from cocoa in people taking warfarin. Keeping cocoa intake small and consistent is a sensible precaution rather than a response to a proven interaction.
chocolate + lithium
Chocolate contains caffeine, a mild diuretic that increases how much lithium the kidneys clear. Because lithium has a narrow therapeutic window, a large, sustained change in caffeine intake can nudge serum lithium levels; adding a steady caffeine habit can lower them, while abruptly stopping one can raise them. Chocolate is a relatively minor caffeine source compared with coffee or tea, so the effect matters most for heavy, consistent chocolate consumers who make a sudden change.
pomegranate + warfarin
Pomegranate contains punicalagins and other polyphenols that inhibit the liver enzymes CYP2C9 and CYP3A4 in laboratory and animal studies, which would slow warfarin metabolism. Case reports describe both a raised INR after heavy or newly started pomegranate juice intake and a falling INR after stopping a habitual juice habit. The effect appears to be genuine but infrequent, and consistency of intake matters more than total avoidance.
alcohol + sertraline
Sertraline (Zoloft) and alcohol both act on the central nervous system. Controlled studies in healthy volunteers did not show sertraline worsening alcohol's effects on thinking or coordination, but the FDA label still advises against drinking on sertraline because alcohol can deepen depression and anxiety, worsen drowsiness and sleep, and blunt the medication's benefit in people being treated for a mood disorder.
alcohol + gabapentin
Gabapentin and alcohol are both central nervous system depressants. Combining them increases drowsiness, dizziness, impaired coordination, and the risk of serious, potentially life-threatening respiratory depression, especially in older adults and people with lung disease, sleep apnea, kidney impairment, or who take opioids or other sedatives.
cbd + clobazam
CBD inhibits CYP2C19, the enzyme that clears N-desmethylclobazam, the active metabolite of clobazam. Taking the two together raises N-desmethylclobazam levels substantially, increasing sedation, drowsiness, drooling, and unsteadiness. This interaction is documented in the FDA-approved Epidiolex prescribing information and in clinical studies in children with epilepsy.
alcohol + escitalopram
The Lexapro label says escitalopram did not increase alcohol's effects on thinking and coordination in a clinical trial, but it still recommends against alcohol, and the Medication Guide says not to drink during treatment. Escitalopram can itself cause sleepiness or slow thinking and reactions, and alcohol adds its own impairment. One published case described serotonin syndrome after a can of beer in a man taking escitalopram with a second antidepressant, clomipramine; a single case is a signal, not proof.
caffeine + clozapine
Caffeine and clozapine are both broken down by the liver enzyme CYP1A2, and caffeine competitively inhibits it. Large changes in caffeine intake - especially starting or stacking energy drinks - can raise clozapine to toxic levels, with a documented case report of severe toxicity and multiorgan failure.
coffee + propranolol
Coffee acutely raises blood pressure and adrenaline levels, which can partly counteract the blood-pressure-lowering effect of propranolol, a non-selective beta-blocker. In a study of 12 healthy adults, pretreatment with propranolol did not change the rise in blood pressure after coffee. There is no good evidence that propranolol slows caffeine clearance: one small study, in patients with alcoholic liver disease, found caffeine clearance went up after 10 days of propranolol.
cbd + valproate
Taking CBD (including prescription Epidiolex and over-the-counter products) together with valproate raises the chance of liver enzyme elevations well above either drug alone, and the combination has been linked to high blood ammonia that can cause confusion or worsening seizures even when liver tests look only mildly abnormal. This pairing should be managed by the prescribing neurologist with baseline and follow-up liver testing.
cbd + warfarin
CBD inhibits the liver enzymes (notably CYP2C9, and also CYP3A4) that clear warfarin, especially its more potent S-enantiomer. Adding CBD to a stable warfarin regimen can slow warfarin breakdown, raise its blood level, push the INR upward, and increase bleeding risk. A published case report described a patient who needed a meaningful warfarin dose reduction after starting CBD.
diazepam + grapefruit
Grapefruit juice contains strong inhibitors of CYP3A4, one of the two enzymes that clear diazepam, and the Valium label says to avoid food or drink containing grapefruit juice during treatment because higher diazepam exposure may cause increased and prolonged sedation. In a study of 8 healthy adults given a single oral dose of diazepam, taking it with grapefruit juice instead of water raised overall exposure 3.2-fold and peak levels 1.5-fold. The evidence covers diazepam taken by mouth, and the study measured blood levels, not sedation.
grapefruit + buspirone
Grapefruit irreversibly inhibits intestinal CYP3A4, the enzyme that destroys most of an oral buspirone dose before it reaches the bloodstream. In a controlled human study, grapefruit juice substantially raised buspirone blood levels, markedly amplifying drowsiness, dizziness, and lightheadedness.
